Get the Stockscreener App
1.97
2.07%
0.04
After Hours:
1.95
-0.02
-1.02%
Biomerica Inc stock is traded at $1.97, with a volume of 30,726.
It is up +2.07% in the last 24 hours and down -15.81% over the past month.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
See More
Previous Close:
$1.93
Open:
$2.055
24h Volume:
30,726
Relative Volume:
1.41
Market Cap:
$6.09M
Revenue:
$4.33M
Net Income/Loss:
$-4.17M
P/E Ratio:
-1.3175
EPS:
-1.4953
Net Cash Flow:
$-3.19M
1W Performance:
-2.48%
1M Performance:
-15.81%
6M Performance:
-17.57%
1Y Performance:
-39.57%
1-Day Range:
$1.9568
$2.11
1-Week Range:
$1.905
$2.18
52-Week Range:
$1.8664
$4.60
Biomerica Inc Stock (BMRA) Company Profile
Name
Biomerica Inc
Sector
Industry
Phone
(949) 379-2875
Address
17571 VON KARMAN AVENUE, IRVINE, CA
Compare BMRA vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
1.97 | 6.18M | 4.33M | -4.17M | -3.19M | -1.4953 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-10-20 | Initiated | Colliers Securities | Buy |
| Jan-04-18 | Initiated | B. Riley FBR, Inc. | Buy |
Biomerica Inc Stock (BMRA) Latest News
Biomerica (BMRA) Slips Slightly to $2.05; Near Key Support Amid Quiet TradingDark Pool Volume - newsline.com
Biomerica (BMRA) Edges Lower, Testing Key Support at $1.95ETF Liquidity - newsline.com
Biomerica (BMRA) Edges Higher as Stock Holds Above Key Support LevelIV Contraction - newsline.com
BMRA Q1 2026 Earnings: Net Loss of $0.44 per Share; Stock Declines 0.92%Analyst Consensus Shift - newsline.com
Biomerica (BMRA) Slides Slightly as Stock Approaches Key Support LevelIceberg Order - newsline.com
Biomerica (BMRA) Q1 2026 Earnings: Narrowing Loss Amid Ongoing Operational ChallengesReturn On Capital - newsline.com
Biomerica, Inc. Announces $500,000 Securities Purchase Agreement and Secured Promissory Note – Form 8-K Filing, May 29, 2026 – Minichart - Minichart
Biomerica Enters Related-Party Deal to Boost Liquidity - TipRanks
Biomerica to Sell 6% Diagnosis Stake for $500,000; Issues 8% Note Pending Transfer - TradingView
Biomerica (BMRA) sells 6% Diagnosis S.A. stake to CEO-affiliated buyers - Stock Titan
Biomerica Inc. (BMRA) Sees Modest Gain as Shares Test Key ResistanceDip Buy Trade - newsline.com
BMRA Q1 2026 Earnings: Operating Loss Widens to $0.44 per Share as Pre-Revenue Biotech Advances Pipeline - newsline.com
Biomerica secures USD 1.75M contract for IVD diagnostic development - Medical Buyer
BMRA Stock Price, Quote & Chart | BIOMERICA INC (NASDAQ:BMRA) - ChartMill
Biomerica Inc. Awarded $1.75 Million Contract for IVD Product Development - geneonline.com
Biomerica (BMRA) Secures Master Services Agreement for Diagnosti - GuruFocus
Biomerica Inc. (BMRA) Holds Near Support Amid Modest PullbackBeta Neutral Pair - The Legal Advocate
Biomerica Wins $1.75M Contract to Develop Diagnostic Tests - Orange County Business Journal
Biomerica signs contract development deal worth over $1.75M By Investing.com - Investing.com Canada
Biomerica lands $1.75 million CDMO master services agreement for IVD diagnostic development - marketscreener.com
Biomerica signs contract development deal worth over $1.75M - Investing.com
Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development - The Manila Times
Undisclosed $1.75M lab deal taps Biomerica’s diagnostic test expertise - Stock Titan
Biomerica Q1 2026 Earnings: Net Loss of $0.44 Per Share Amid Lack of Revenue DisclosureManagement Guidance Update - The Legal Advocate
Biomerica Inc. (BMRA) Q1 2026 Earnings: Negative EPS Persists Amid Pre-Revenue StageEarnings Season Review - The Legal Advocate
BMRA Q1 2026 Earnings: Biomerica Reports Net Loss of $0.44 Per Share Amid Ongoing Development Efforts - Newser
Biomerica (BMRA) Q1 2026 Earnings: Revenue $N/A, Matching ViewsExpert Entry Points - Newser
ConsumerDirect names Gary Lu as chief financial officer - Investing.com UK
ConsumerDirect names Gary Lu as chief financial officer By Investing.com - Investing.com South Africa
ConsumerDirect adds new CFO to scale its subscription business - Stock Titan
Biomerica (BMRA) Stock Analysis: Falls -3.85%, Watching $2.14 2026-05-18Most Watched Stocks - newser.com
Should You Sell Biomerica (BMRA) After -2.90% Drop? 2026-05-17Crowd Sentiment Stocks - Newser
TradingKey - TradingKey
What Biomerica (BMRA) subscription metrics reveal about retention | BMRA Q1 2026: Biomerica Posts Wider Loss Amid Cost PressureCatalyst Event - Newser
BMRA | BIOMERICA INC Insider Trading - Quiver Quantitative
What nobody tells you about Biomerica (BMRA) stock (Smart Money Outflows) 2026-05-08Value ETF - The Legal Advocate
Why are smart money investors paying attention to Biomerica (BMRA)? (On the Radar) 2026-05-07Verified Stock Signals - newser.com
How Biomerica (BMRA) competitive position is evolving (Bullish Momentum) 2026-05-06Social Investment Platform - newser.com
Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 - Weekly Voice
An IBS diet-guided therapy gets a slot at the world's biggest GI meeting - Stock Titan
BMRA (Biomerica) falls 0.47% after reporting Q1 2026 negative EPS of $-0.44 with no available analyst consensus estimates.Cash Flow Report - The Legal Advocate
BMRA (Biomerica Inc.) posts 1.9 percent year-over-year Q1 2026 revenue dip, shares gain 4.27 percent. - Cổng thông tin điện tử tỉnh Lào Cai
BMRA (Biomerica Inc.) slips 0.91% following Q1 2026 earnings release with no available analyst consensus estimates.Hedge Fund Inspired Picks - Xã Thanh Hà
Biomerica Q3 Sales Fall, Net Loss Widens Amid Restructuring - Orange County Business Journal
BMRA Biomerica reports 1.9% year-over-year Q1 2026 revenue decline, shares drop 2.52% in today’s session.Popular Market Picks - Newser
Biomerica (BMRA) Secures Medicare Coverage for inFoods IBS Tests - GuruFocus
Biomerica Inc Stock (BMRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):